Details for Patent: 5,827,727
✉ Email this page to a colleague
Title: | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
Abstract: | A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers. The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner. In particular, deaminase, PPL, PLE and subtilisn are used to resolve 1,3-oxathiolane nucleoside enantiomers. |
Inventor(s): | Liotta; Dennis C. (McDonough, GA), Schinazi; Raymond F. (Decatur, GA), Choi; Woo-Baeg (North Brunswick, NJ), Cheng; Yung-Chi (Woodbridge, CT) |
Assignee: | Emory University (Atlanta, GA) Yale University (New Haven, CT) |
Filing Date: | Jun 07, 1995 |
Application Number: | 08/483,653 |
Claims: | 1. A method for the resolution of a .beta.-1,3-oxathiolane pyrimidine nucleoside, comprising the steps of selectively hydrolyzing a 5'-O-acyl derivative of the nucleoside with an enzyme selected from the group consisting of pig liver esterase, porcine pancreatic lipase, and subtilisin. 2. The method of claim 1, wherein the enzyme is pig liver esterase. 3. The method of claim 1, wherein the enzyme is porcine pancreatic lipase. 4. The method of claim 1, wherein the enzyme is subtilisin. 5. The method of claim 1, wherein the 5'-O-acyl group is the residue of an alkyl carboxylic acid selected from the group consisting of acetic acid, propionic acid, butyric acid, and pentanoic acid. 6. The method of claim 5, wherein the 5'-O-acyl group is acetic acid. 7. The method of claim 5, wherein the 5'-O-acyl group is propionic acid. 8. The method of claim 5, wherein the 5'-O-acyl group is butyric acid. 9. The method of claim 5, wherein the 5'-O-acyl group is pentanoic acid. 10. A method for the resolution of cis-2-hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane comprising selectively deaminating it with cytidine deaminase. 11. A method for the resolution of cis-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane comprising selectively deaminating it with cytidine deaminase. |